AbbVie Inc. Price Today
AbbVie Inc.
ABBV
Healthcare
$260.64B
💰
Market Cap
34.8
💸
Price to Earnings
$4.2
🎉
EPS
+72
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
15 |
Strong Buy |
5 |
Hold |
16 |
Sell |
0 |
Strong Sell |
0 |
ABBV Price Forecast Target
147.7 👉 195.0 +32%
ABBV EPS Forecast
4.2 👉 11.1 +160%
Financials
Profit Margin
16 %
Revenue Growth
-4.9 %
Dividend
$ 5.92
Held Percent
0.1% - Insiders
71.4% - Institutions
28.5% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $23.7B
-
💰 Blackrock Inc. $20.5B
-
💰 State Street Corporation $11.4B
-
💰 JP Morgan Chase & Company $8.6B
-
💰 Capital International Investors $6.3B
Stock Ideas
Daniel Sundheim Portfolio
Daniel Sundheim is the founder of D1 Capital Partners, a renowned multi-billion dollar global investment firm. Prior to starting his own firm, Sundheim worked as a portfolio manager at prestigious hedge funds before breaking out on his own in 2018. …
Carl Icahn Portfolio
With a staggering net worth exceeding $16 billion, Icahn has made a lasting impact on the stock market as the founder and manager of Icahn Enterprises. Known as a 'corporate raider,' Icahn has gained fame for his relentless pursuit of undervalued co…
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…
Steven Cohen Portfolio
Steven Cohen, the legendary trader and billionaire founder of Stamford-based SAC Capital, has established himself as a force to be reckoned with in the hedge fund industry. With a staggering net worth of $8 billion and an impressive $14 billion in …📮FAQ
Some Frequently Asked Questions.
The AbbVie Inc. industry is Drug Manufacturers—General
The AbbVie Inc. sector is Healthcare
The AbbVie Inc. forecasted predicted Price to Earnings PE ratio is 13.4
The AbbVie Inc. Price to Earnings PE ratio is 34.8
The Market Capitalization of AbbVie Inc. is $260.64B
There are total of 1761519745 float shares with 71.4% held by Institutions and 0.1% held by insiders
The MAbbVie Inc. forecasted Earnings per Share EPS is $11.1
The AbbVie Inc. Earnings per Share EPS is 4.2
The AbbVie Inc. company has $41527000000 gross profits with 16 profit margins
The AbbVie Inc. Earnings Growth is 1.235% with 1.19% quarterly earnings growth
The AbbVie Inc. Revenue is $56022999040 with -0.049 revenue growth
The price target for AbbVie Inc. stock is $195.0 for the high target and $135.0 for the low target
The consensus analyst recommendations for AbbVie Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for AbbVie Inc. is Buy, with the following breakdown:
- Buy: 15
- Strong Buy: 5
- Hold: 16
- Sell: 0
- Strong Sell: 0
The Beta of AbbVie Inc. is 0.5
The dividend of AbbVie Inc. is $5.92
The dividend yield of AbbVie Inc. is 0.0401%
The biggest institutional and mutual fund holders of AbbVie Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- JP Morgan Chase & Company
The AbbVie Inc. ESG Score is 72, with the following breakdown:
- E: 1.12
- S: 16.77
- G: 9.95